Back

Frequency and clinical impact of urinary tract infections in heart failure patients receiving SGLT-2 inhibitor therapy

18 May 2025 (13:00 - 14:20)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure (2) Clinical HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Duygu Inan

Basaksehir Cam and Sakura City Hospital, Istanbul (Turkiye)

5 More presentations in this session

Presentation thumbnail
Resolution of left bundle branch block in non-ischaemic cardiomyopathy patients
Doctor I. Chung (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Progress in the management of heart failure. a case analysis of a university cardiology clinic over a 15year period
Mr M. Koutroulos (Alexandroupolis, GR)
Abstract Slides Video
Presentation thumbnail
Long-term mortality and predictors for hospitalized patients with stress-induced cardiomyopathy due to an acute non-cardiac illness
Professor D. Park (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Exploring the relationship between obstetric complications and peripartum cardiomyopathy
Ms E. Shalowitz (Aurora, US)
Abstract Slides Video
Presentation thumbnail
Two sides of the same coin: ischemic and non-ischemic etiology in acute heart failure
Doctor M. Balabayeva (Aktobe, KZ)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in acute heart failure (2)

The Event

Event poster

Heart Failure 2025

18 May 2025 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Urinary tract infections and sodium-glucose cotransporter 2 inhibitors in heart transplant recipients: a retrospective cohort study
thumbnail
Congress Presentation
Real-life data on the tolerability of SGLT2 inhibitors in elderly patients with heart failure
thumbnail
Congress Presentation
Impact of SGLT2 inhibitor on renal function and cardiovascular outcomes in heart failure: Korean heart failure III registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources